BE890521A - Composition prophylactique et therapeutique pour l'hyperplasie de la prostate et son utilisation - Google Patents

Composition prophylactique et therapeutique pour l'hyperplasie de la prostate et son utilisation

Info

Publication number
BE890521A
BE890521A BE0/206084A BE206084A BE890521A BE 890521 A BE890521 A BE 890521A BE 0/206084 A BE0/206084 A BE 0/206084A BE 206084 A BE206084 A BE 206084A BE 890521 A BE890521 A BE 890521A
Authority
BE
Belgium
Prior art keywords
prophylactic
therapeutic composition
prostate hyperplasia
hyperplasia
prostate
Prior art date
Application number
BE0/206084A
Other languages
English (en)
French (fr)
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of BE890521A publication Critical patent/BE890521A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
BE0/206084A 1981-05-22 1981-09-28 Composition prophylactique et therapeutique pour l'hyperplasie de la prostate et son utilisation BE890521A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19813121153 DE3121153A1 (de) 1981-05-22 1981-05-22 "verwendung von aromatase-hemmern zur prophylaxe und therapie der prostatahyperplasie"

Publications (1)

Publication Number Publication Date
BE890521A true BE890521A (fr) 1982-03-29

Family

ID=6133383

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/206084A BE890521A (fr) 1981-05-22 1981-09-28 Composition prophylactique et therapeutique pour l'hyperplasie de la prostate et son utilisation

Country Status (13)

Country Link
US (1) US4596797A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS57193411A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU563524B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE (1) BE890521A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH (1) CH648485A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE3121153A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK354781A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB2100601B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IT (1) IT1168028B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
LU (1) LU83544A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (1) NL8103874A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SE (1) SE462639B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA823500B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0114033B1 (de) * 1982-12-21 1988-10-12 Ciba-Geigy Ag Substituierte Azabicycloalkane, ihre Verwendung, pharmazeutische Präparate, welche diese Verbindungen enthalten, und Verfahren zur Herstellung dieser Verbindungen
DE3323321A1 (de) * 1983-06-24 1985-01-03 Schering AG, 1000 Berlin und 4709 Bergkamen Prophylaxe und therapie von koronaren herzkrankheiten durch senkung des oestrogenspiegels
GB8531747D0 (en) * 1985-12-24 1986-02-05 Erba Farmitalia 10beta-alkynylestrene derivatives
GB8624251D0 (en) * 1986-10-09 1986-11-12 Erba Farmitalia "1,2-beta-methylene-4-substituted androstene-3,17 dione derivatives
US5595985A (en) * 1989-03-10 1997-01-21 Endorecherche Inc. Combination therapy for prophylaxis and/or treatment of benign prostatic hyperplasia
AU643445B2 (en) * 1989-07-07 1993-11-18 Endorecherche Inc. Combination therapy for prophylaxis and/or treatment of benign prostatic hyperplasia
US5227375A (en) * 1990-02-08 1993-07-13 Endorecherche, Inc. Aromatase inhibitors
KR0180008B1 (ko) * 1991-03-28 1999-04-01 야마구찌 다까시 신규 옥사-또는 아자스테로이드 유체
US6833373B1 (en) 1998-12-23 2004-12-21 G.D. Searle & Co. Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
US6649645B1 (en) * 1998-12-23 2003-11-18 Pharmacia Corporation Combination therapy of radiation and a COX-2 inhibitor for treatment of neoplasia
EP1140183A1 (en) 1998-12-23 2001-10-10 G.D. Searle & Co. Use of a matrix metalloproteinase inhibitor and an integrin antagonist in the treatment of neoplasia
US6858598B1 (en) 1998-12-23 2005-02-22 G. D. Searle & Co. Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
US7939517B2 (en) * 2004-07-21 2011-05-10 Kneller Bruce W 1,4,6-androstatriene-3,17-dione (“ATD”) for therapeutic uses
EP1854465A1 (en) 2006-05-12 2007-11-14 Alexander Tobias Teichmann Use of 4,17 beta-dihydroxyandrost-4-ene-3-one for treating cancers
US20080245375A1 (en) * 2007-04-05 2008-10-09 Medtronic Vascular, Inc. Benign Prostatic Hyperplasia Treatments
EP2500062B1 (en) * 2007-11-13 2015-08-12 Curadis GmbH C-19 steroids for specific therapeutic uses
CA2794565C (en) 2010-04-08 2018-08-21 Emory University Substituted androst-4-ene diones
US20160361380A1 (en) 2015-06-12 2016-12-15 Nymox Corporation Combination compositions for treating disorders requiring removal or destruction of unwanted cellular proliferations
US10183058B2 (en) 2016-06-17 2019-01-22 Nymox Corporation Method of preventing or reducing the progression of prostate cancer
US10172910B2 (en) 2016-07-28 2019-01-08 Nymox Corporation Method of preventing or reducing the incidence of acute urinary retention
US10532081B2 (en) 2016-09-07 2020-01-14 Nymox Corporation Method of ameliorating or preventing the worsening or the progression of symptoms of BPH
US10335453B2 (en) 2017-03-01 2019-07-02 Nymox Corporation Compositions and methods for improving sexual function
EP3666276A1 (en) 2018-12-14 2020-06-17 dcic Biopharmaceutical Limited Medication against estrogen-receptor beta (erbeta) positive breast tumor

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3423507A (en) * 1966-02-25 1969-01-21 Schering Corp Method of treating benign prostratic hypertrophy
US4055641A (en) * 1976-05-10 1977-10-25 Richardson-Merrell Inc. Method of treating benign prostatic hypertrophy
DE2817157A1 (de) * 1978-04-17 1979-10-25 Schering Ag Verwendung von antioestrogenen und antigonadotrop wirkenden antiandrogenen zur prophylaxe und therapie der prostatahyperplasie
US4235893A (en) * 1978-05-08 1980-11-25 Brodie Angela M Ester derivatives of 4-hydroxy-4-androstene-3,17-dione and a method for inhibiting estrogen biosynthesis
EP0100566B1 (en) * 1982-07-14 1986-02-19 Akzo N.V. Novel 19-thio-androstane derivatives

Also Published As

Publication number Publication date
CH648485A5 (de) 1985-03-29
DK354781A (da) 1982-11-23
JPS57193411A (en) 1982-11-27
US4596797A (en) 1986-06-24
GB2100601B (en) 1986-02-05
DE3121153C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1991-06-20
DE3121153A1 (de) 1982-12-09
NL8103874A (nl) 1982-12-16
SE8104625L (sv) 1982-11-23
AU8407482A (en) 1982-11-25
IT8124117A0 (it) 1981-09-24
ZA823500B (en) 1983-03-30
IT1168028B (it) 1987-05-20
GB2100601A (en) 1983-01-06
LU83544A1 (de) 1981-12-01
AU563524B2 (en) 1987-07-16
SE462639B (sv) 1990-08-06
JPH0150206B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1989-10-27

Similar Documents

Publication Publication Date Title
BE890522A (fr) Composition prophylactique et therapeutique pour l'hyperplasie de la prostate et son utilisation
BE890521A (fr) Composition prophylactique et therapeutique pour l'hyperplasie de la prostate et son utilisation
GB2097803B (en) Modified ionomer and application thereof
ZA824233B (en) Therapeutic method and method for making compositions for use therein
BE875634A (fr) Compositions pharmaceutiques et leur utilisation pour le traitement prophylactique et therapeutique de l'hyperplasie de la prostate
FR2559739B1 (fr) Appareil mobile d'arret d'aeronefs
JPS5567305A (en) Antifrothing agent and use for its water system antifrothing
MA19609A1 (fr) N-phenyl sufonyl -N' pyrimidinyl-et-triazinylurees
DE3262017D1 (en) Sterile dressing and preparation thereof
JPS5721350A (en) Perfume composition and use
GB2108962B (en) Cyclopropylmethyl esters and use as perfuming agents
DK416383A (da) Inkontinensudstyr til kvinder
ES510498A0 (es) "procedimiento de preparar amidoaminoacidos y similares".
TR21520A (tr) Alkil tert-alkil'in terkibine coezuelmesi icin usul
DE3587638D1 (de) Sphärisches Schwenkungsverfahren und -gerät.
IT1098889B (it) Procedimento e dispositivo per l'utilizzazione di scorie metallurgiche,in particolare di scorie di altiforni
TR21606A (tr) Benzilkarbamoilpiridin'in bazi yeni tuerevleri
JPS5548597A (en) Artificial hand and arm
EG15753A (en) Pest-combating agents,their prepotion and use
DE3362345D1 (en) Mixtures of specific 1,2-cycloaliphatic diepoxydes, and use thereof
FR2531348B1 (fr) Melangeur de pulpes et d'agents de blanchiment
PH20030A (en) New 17,18-dehydro-apovincaminol-3',4',5'-trimethoxy-benzoate and use thereof
EP0222912A4 (en) AGENT FOR TREATING ARTERIOSCLEROSIS.
BR8201041A (pt) Recalcadora de via ferrea
LU80584A1 (fr) Installation pour la prehension et la distribution d'articles

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: SCHERING A.G.

Effective date: 19950930